CSLG2 Antibody

Shipped with Ice Packs
In Stock

Description

SCG2 (Secretogranin II) Antibody

Description: Secretogranin II (SCG2) is a neuroendocrine protein belonging to the granin family. Antibodies targeting SCG2 (e.g., ab126935) are used in research applications:

  • Applications: Immunohistochemistry (IHC-P), Western blot (WB)

  • Species Reactivity: Human, Mouse, Rat

  • Target Epitope: Recombinant fragment within Human SCG2 amino acids 1-200

  • Validation: Confirmed reactivity in U87 xenograft, mouse forebrain, and human colon carcinoma samples

Key Findings:

ParameterValue/Result
Predicted Band Size71 kDa
Tested Dilutions1:250 (IHC), 1:500–1:1000 (WB)
Cross-reactivityNone with CCSA-3, CCSA-4, or EPCA-2

GUCY2C (Guanylyl Cyclase C) Antibody

Description: GUCY2C is an intestinal protein investigated as a therapeutic target in colorectal cancer (CRC):

  • Therapeutic Role: Biomarker for CRC vaccines, CAR-T therapies, and bispecific antibodies

  • Clinical Trials: Phase IIa trials ongoing for GUCY2C-targeted vaccines (NCT04111172)

Research Insights:

  • Universal expression in CRC (>95% of cases)

  • Limited expression in normal tissues (intestinal mucosa only)

  • Potential companion diagnostic utility for anti-EGFR therapies

CCSA-2 (Colon Cancer-Specific Antigen 2) Antibody

Diagnostic Performance:

CohortSensitivitySpecificityAUC
Colorectal Cancer95.6%97.7%0.90
Advanced Adenoma100%78.4%0.90
Nonadvanced Adenoma64.4%78.4%-

CCSA-2 ELISA demonstrated 97.3% sensitivity and 78.4% specificity for detecting advanced colorectal neoplasia at a cutoff of 10.8 µg/mL .

IgG2 Antibody Subclass

Functional Characteristics:

PropertyIgG2 vs. Other Subclasses
FcγR BindingLower affinity for FcγRIIa
Complement ActivationReduced C1q binding
Agonistic ActivityFcγR-independent (unique to IgG2)
Clinical UseSuperagonistic anti-CD40 mAbs

Key studies show IgG2 antibodies induce T-cell infiltration in pancreatic tumors and reduce stromal density in neoadjuvant settings .

SARS-CoV-2 Spike IgG2 Antibodies

Therapeutic Implications:

  • Neutralizing IgG2 antibodies correlate with >90% ACE2 receptor binding inhibition

  • Levels >5,000 AU associated with breakthrough infection prevention

  • Structural analysis reveals broad-spectrum binding to Omicron subvariants (e.g., XBB.1.5, EG.5.1) via unique RBD epitopes

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Composition: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
CSLG2 antibody; At4g24000 antibody; T19F6.18 antibody; T32A16.170Cellulose synthase-like protein G2 antibody; AtCslG2 antibody; EC 2.4.1.- antibody
Target Names
CSLG2
Uniprot No.

Target Background

Function
CSLG2 Antibody is believed to target a Golgi-localized beta-glycan synthase responsible for polymerizing the backbones of noncellulosic polysaccharides (hemicelluloses) within the plant cell wall.
Database Links

KEGG: ath:AT4G24000

STRING: 3702.AT4G24000.1

UniGene: At.27174

Protein Families
Glycosyltransferase 2 family, Plant cellulose synthase-like G subfamily
Subcellular Location
Golgi apparatus membrane; Multi-pass membrane protein.
Tissue Specificity
Expressed in young seedlings, primarily in the vascular tissue.

Q&A

What is CSLM2 and what cellular functions does it perform?

CSLM2 belongs to the cellulose synthase-like M (CSLM) family of proteins involved in plant cell wall biosynthesis. Based on current research, CSLM2 appears to play a significant role in the biosynthesis of type II arabinogalactan (AG) linkages. Functional characterization studies in spinach CSLM2 (also known as SOAP5) identified two critical amino acids for glucuronosylation of triterpenoid aglycone. These amino acids are part of the core motifs in the active site of cellulose synthase (CesA), specifically the ED and QxxRW motifs, which in CSLM2 are modified to ES and QxxKW .

Experiments involving site-directed mutagenesis of spinach CSLM2 demonstrated that changing these unique residues to CesA-like residues (S442D or K483R) reduced glucuronosylation activity approximately 10-fold, with activity further reduced 100-fold when both amino acids were changed . This suggests CSLM2's specialized role in polysaccharide synthesis differs from traditional cellulose synthases.

How does CSLM2 expression affect plant cell wall composition?

Ectopic expression of CSLM2 in plants leads to several notable changes in cell wall composition and structure. Research shows that CSLM2 expression affects:

  • Epidermal cell walls - Thickening of outer epidermal walls observed in both CSLM1 and CSLM2a ectopically expressing lines

  • Pectin composition - Increased epitopes for methyl-esterified (LM20) and de-esterified (LM19) homogalacturonan in epidermal walls

  • Arabinogalactan distribution - Changes in arabinogalactan (AG) epitopes (LM2), which could be associated with sidechains on rhamnogalacturonan-I or arabinogalactan-proteins

  • Wall integrity issues - In CSLM2a ectopically expressing lines, time-course experiments revealed aberrant lower epidermal cell wall formation appearing by day 7, with incomplete wall formation and wall stubs

These findings suggest CSLM2's involvement in type II arabinogalactan synthesis and wall integrity maintenance.

What techniques are commonly used to detect and visualize CSLM2 expression?

Several complementary techniques have proven effective for detecting and visualizing CSLM2 expression and its effects on cell walls:

  • Quantitative PCR (qPCR) - For measuring relative gene expression levels over time (e.g., maximum expression of CSLM2a was observed on day 4 in time-course experiments)

  • Immunofluorescence microscopy - Using antibodies like M22 (for rhamnogalacturonan-I), LM2 (arabinogalactan), LM19 and LM20 (homogalacturonan) to visualize epitope distribution in cell walls

  • Transmission electron microscopy (TEM) with immunogold labeling - Providing higher resolution localization of specific epitopes within cell wall layers

  • Toluidine blue staining - For detecting aberrant cell wall formation in ectopically expressing plants

  • Scanning electron microscopy (SEM) - For examining seed surface characteristics in transformed lines

When conducting these analyses, it's recommended to examine multiple independent transgenic lines and perform time-course experiments to track developmental changes in cell wall composition.

What are the best methods for generating and validating CSLM2-specific antibodies?

Generating specific antibodies for CSLM2 research requires careful consideration of epitope selection and validation. While the search results don't provide specific protocols for CSLM2 antibody generation, general principles for antibody development from the literature can be applied:

  • Epitope Selection and Antibody Generation:

    • Select unique regions of CSLM2 protein sequence (particularly Ala50-Gly608 predicted regions, similar to approaches used for other cell wall proteins)

    • Consider using monoclonal antibody approaches for greater specificity, similar to the approach used for Desmoglein-2 antibody (clone #141409)

    • Express recombinant protein fragments in appropriate systems for immunization

  • Validation Strategy:

    • Western blotting against plant tissue expressing CSLM2 and control/knockout samples

    • Immunocytochemistry/immunofluorescence on fixed plant tissues with appropriate controls

    • Use multiple independent antibodies raised against different epitopes if possible

    • Compare labeling patterns with gene expression data and protein localization predictions

  • Specificity Testing:

    • Test against wild-type and knockout/knockdown lines to confirm specificity

    • Evaluate cross-reactivity with other CSLM family members through comparative immunolabeling

For validation, researchers should follow rigorous controls similar to those demonstrated for the human Desmoglein-2 antibody, which was validated using multiple techniques including Western blot, immunocytochemistry, and Simple Western™ analysis .

How can I optimize immunolabeling protocols for detecting CSLM2 in plant cell walls?

Optimizing immunolabeling protocols for CSLM2 detection requires attention to several critical factors:

  • Sample Preparation:

    • For light microscopy: Use fresh tissue fixation (4% paraformaldehyde) followed by careful embedding and sectioning

    • For TEM: Use high-pressure freezing and freeze substitution rather than chemical fixation when possible to better preserve cell wall epitopes

    • Consider wall permeabilization treatments to improve antibody penetration

  • Antibody Dilution and Incubation:

    • Determine optimal antibody concentration through titration experiments (typically starting at 10 μg/mL based on protocols used for other cell wall antibodies)

    • Optimize incubation time and temperature (typically 3 hours at room temperature or overnight at 4°C)

    • Use appropriate blocking solutions to minimize non-specific binding

  • Detection Systems:

    • For fluorescence: Use appropriate secondary antibodies (e.g., NorthernLights™ 557-conjugated Anti-Mouse IgG)

    • For TEM: Use gold-conjugated secondary antibodies of appropriate size (typically 10-15nm)

    • Include DAPI counterstaining for nucleus visualization in fluorescence microscopy

  • Controls to Include:

    • Negative controls: primary antibody omission, non-expressing tissues, pre-immune serum

    • Positive controls: tissues known to express CSLM2

    • Comparative controls: multiple tissue types and developmental stages

The immunofluorescence approach used for cell wall epitope detection in CSLM2 ectopic expression studies provides a good methodological foundation, with attention to epitope preservation and appropriate controls .

What quantification methods are most reliable for analyzing CSLM2 expression and its effects?

Reliable quantification of CSLM2 expression and its effects requires multiple complementary approaches:

  • Gene Expression Quantification:

    • RT-qPCR with appropriate reference genes for normalization

    • RNA-seq for genome-wide expression analysis

    • Consider time-course experiments to capture dynamic expression patterns

  • Protein Level Quantification:

    • Western blotting with densitometry analysis

    • Simple Western™ automated capillary-based immunoassays for higher precision quantification

    • ELISA-based approaches for more quantitative analysis

  • Cell Wall Composition Analysis:

    • Monosaccharide composition analysis

    • Linkage analysis to detect specific changes in polysaccharide structure

    • Quantification of immunolabeling intensity across multiple samples and microscopy fields

  • Phenotypic Measurements:

    • Morphometric analysis of cell dimensions and wall thickness

    • Quantification of wall abnormalities (e.g., percentage of cells with wall stubs)

    • Statistical analysis comparing multiple independent transgenic lines

For the most robust analysis, researchers should combine multiple quantification approaches. For example, in CSLM2 studies, researchers employed both qPCR for gene expression quantification and measured wall thickness changes through TEM, correlating gene expression levels with phenotypic outcomes over a time course .

How can biophysics-informed models improve antibody design for CSLM2 research?

Biophysics-informed models represent a cutting-edge approach to designing antibodies with greater specificity for research applications, including potential applications for CSLM2 research:

  • Mode-Based Modeling Approach:

    • Identify distinct binding modes associated with specific ligands

    • Train models on experimentally selected antibodies to predict affinity and specificity

    • Disentangle multiple binding modes even for chemically similar epitopes

  • Applications for CSLM2 Research:

    • Design antibodies that can distinguish between highly similar CSLM family members

    • Create antibodies specific to different functional domains or conformational states of CSLM2

    • Generate antibodies with customized cross-reactivity profiles for comparative studies

  • Implementation Strategy:

    • Conduct phage display experiments with multiple rounds of selection

    • Build computational models based on selection data

    • Test model predictions experimentally to validate novel antibody sequences with desired specificity

Research demonstrates that this approach can successfully predict antibody variants not present in initial libraries that maintain specificity for target ligands. The model's capacity to propose novel antibody sequences with customized specificity profiles would be particularly valuable for distinguishing between closely related CSLM family members .

What are the most effective strategies for studying CSLM2 interactions with other cell wall components?

Studying CSLM2 interactions with other cell wall components requires sophisticated approaches that go beyond basic localization:

  • Co-localization and Proximity Studies:

    • Dual immunolabeling with antibodies against CSLM2 and potential interacting partners

    • Super-resolution microscopy to improve spatial resolution below diffraction limit

    • Proximity ligation assays to detect protein-protein interactions in situ

  • Biochemical Interaction Analysis:

    • Co-immunoprecipitation of CSLM2 with interacting proteins

    • Pull-down assays using recombinant CSLM2 domains

    • Crosslinking approaches to capture transient interactions

  • Genetic Approaches:

    • Gene co-expression analysis to identify potential functional partners

    • Genetic interaction studies using double mutants or RNAi approaches

    • CRISPR-based genome editing to modify specific interaction domains

  • Structural Analysis:

    • Cryo-electron microscopy of CSLM2-containing complexes

    • X-ray crystallography of CSLM2 domains with binding partners

    • Molecular modeling based on homologous structures

Evidence from immunogold TEM studies of CSLM ectopically expressing plants shows changes in epitope distribution patterns that suggest altered interactions with cell wall components. For example, the RG-I epitope (detected by M22) was found predominantly adjacent to the inner wall or in internal membranes in CSLM-expressing lines, whereas in controls the epitope was only detected in the wall .

How can CSLM2 antibodies be used to understand plant stress responses and cell wall remodeling?

CSLM2 antibodies offer powerful tools for investigating stress responses and cell wall remodeling:

  • Stress-Induced Changes in CSLM2 Expression:

    • Immunoblotting and immunolabeling to track CSLM2 protein levels and localization during stress

    • Comparison across multiple stress conditions (drought, salinity, pathogens)

    • Correlation with transcriptomic data on stress-responsive gene expression

  • Cell Wall Remodeling Visualization:

    • Time-course immunolabeling during stress response

    • 3D reconstruction of immunolabeled tissues to track spatial patterns of wall remodeling

    • Quantitative analysis of epitope distribution changes

  • Functional Studies:

    • Antibody inhibition experiments to block CSLM2 function during stress response

    • Combination with metabolic labeling to track newly synthesized wall components

    • Correlative light and electron microscopy for connecting molecular changes to ultrastructural remodeling

  • Comparative Studies:

    • Cross-species immunolabeling to identify conserved stress response mechanisms

    • Analysis across different tissue types to identify tissue-specific responses

    • Developmental stage comparisons to identify age-dependent responses

The observed thickening of outer epidermal walls and altered distribution of cell wall epitopes in CSLM2 ectopically expressing plants suggests a role in wall remodeling that could be relevant to stress responses . Researchers could leverage these observations to investigate natural wall remodeling during environmental challenges.

How can contradictory immunolabeling results for CSLM2 be resolved?

Contradictory immunolabeling results are common challenges in antibody-based research. Here's a methodical approach to resolving such contradictions:

  • Antibody Validation Reassessment:

    • Confirm antibody specificity using knockout/knockdown controls

    • Test multiple antibodies targeting different epitopes of CSLM2

    • Validate antibody lots for consistency (lot-to-lot variation can occur)

  • Technical Considerations:

    • Examine fixation and sample preparation effects on epitope accessibility

    • Compare different detection systems (fluorescence vs. enzymatic)

    • Evaluate blocking conditions and non-specific binding

    • Standardize image acquisition parameters across experiments

  • Biological Interpretation:

    • Consider developmental stage differences in CSLM2 expression/localization

    • Evaluate tissue-specific differences in cell wall composition affecting epitope accessibility

    • Assess possible post-translational modifications affecting antibody recognition

    • Examine potential conformational changes in CSLM2 under different conditions

  • Complementary Approaches:

    • Supplement immunolabeling with gene expression analysis

    • Add fluorescent protein tagging approaches (if genetically tractable)

    • Employ biochemical fractionation to confirm localization

In CSLM research, time-course experiments revealed that aberrant cell wall phenotypes appeared at different times for CSLM1 (day 5) versus CSLM2a (day 7) expressing plants . This temporal difference highlights the importance of considering timing when interpreting seemingly contradictory results.

What statistical approaches are most appropriate for analyzing CSLM2 immunolabeling data?

Robust statistical analysis of immunolabeling data requires consideration of several factors:

  • Quantification Approaches:

    • Intensity measurements: Mean fluorescence intensity, integrated density

    • Distribution analysis: Coefficient of variation, clustering algorithms

    • Colocalization metrics: Pearson's correlation, Manders' coefficients

    • Morphological measurements: Wall thickness, cell dimensions

  • Experimental Design Considerations:

    • Include sufficient biological replicates (minimum 3-4 independent lines)

    • Analyze multiple fields per sample (10-15 fields recommended)

    • Include technical replicates and control for batch effects

    • Plan for appropriate statistical tests based on data distribution

  • Recommended Statistical Tests:

    • For normally distributed data: ANOVA with post-hoc tests, t-tests

    • For non-normally distributed data: Non-parametric alternatives (Mann-Whitney, Kruskal-Wallis)

    • For complex datasets: Linear mixed models accounting for nested variables

    • For spatial data: Spatial statistics approaches (Ripley's K function, etc.)

  • Visualization Approaches:

    • Box plots showing distribution of measurements

    • Violin plots for better visualization of data distribution

    • Heatmaps for multivariate analysis

    • Scatter plots for correlation analysis

In the CSLM studies, researchers tested multiple independent transgenic lines (typically 3-4) to account for potential position effects and genetic background variation . This approach strengthens statistical robustness and should be considered standard practice.

How can we distinguish between direct and indirect effects of CSLM2 on cell wall composition?

Distinguishing direct from indirect effects requires careful experimental design and mechanistic analysis:

  • Temporal Analysis:

    • Track gene expression, protein accumulation, and phenotypic changes over time

    • Establish sequence of events through time-course experiments

    • Identify earliest detectable changes as potential direct effects

  • Domain-Specific Approaches:

    • Express truncated or mutated versions of CSLM2 (e.g., catalytically inactive)

    • Identify domains required for specific cellular effects

    • Use point mutations affecting specific functions (similar to S442D or K483R mutations in spinach CSLM2)

  • Substrate Analysis:

    • Identify direct substrates through in vitro enzymatic assays

    • Track metabolic fate of potential substrates in vivo

    • Conduct metabolic labeling studies to follow product formation

  • Combined Approaches:

    • Correlate biochemical activity with observed phenotypes

    • Use genetic complementation to rescue specific aspects of mutant phenotypes

    • Employ systems biology approaches to model potential direct vs. cascade effects

The research on spinach CSLM2 provides a good example of distinguishing direct effects - its role in glucuronosylation of triterpenoid aglycone was directly demonstrated through biochemical assays, while effects on cell wall structure required more complex interpretation .

What emerging technologies will advance CSLM2 antibody research?

Several emerging technologies show promise for advancing CSLM2 antibody research:

  • Advanced Imaging Technologies:

    • Super-resolution microscopy (STORM, PALM, SIM) for nanoscale visualization of CSLM2 localization

    • Expansion microscopy for physical magnification of samples

    • Correlative light and electron microscopy (CLEM) for connecting molecular and ultrastructural data

    • Live-cell imaging with novel cell wall probes for dynamic studies

  • Antibody Engineering Approaches:

    • Nanobodies (single-domain antibodies) for improved penetration into dense cell wall structures

    • Bispecific antibodies for simultaneous detection of CSLM2 and interacting partners

    • Computationally designed antibodies with enhanced specificity and affinity

    • Split-antibody complementation for detecting protein-protein interactions

  • Multi-omics Integration:

    • Spatial transcriptomics combined with immunolabeling

    • Glycomics approaches to connect CSLM2 activity with cell wall polysaccharide profiles

    • Proteomics of immunoprecipitated complexes

    • Integration with metabolomics data for pathway analysis

  • High-throughput Approaches:

    • Automated imaging and image analysis for large-scale phenotyping

    • Machine learning for pattern recognition in complex immunolabeling datasets

    • CRISPR screens combined with antibody-based detection

Biophysics-informed models for antibody design represent a particularly promising advance, as they enable the design of antibodies with customized specificity profiles that could distinguish between highly similar CSLM family members or different functional states .

How might CSLM2 research contribute to our understanding of plant evolution and adaptation?

CSLM2 research offers several avenues for exploring plant evolution and adaptation:

  • Evolutionary Analysis:

    • Comparative genomics of CSLM genes across plant lineages

    • Analysis of selection pressure on specific domains

    • Reconstruction of ancestral CSLM sequences and functional testing

    • Investigation of CSLM gene family expansion/contraction events

  • Adaptive Significance:

    • Analysis of CSLM2 expression and function across ecological gradients

    • Investigation of natural variation in CSLM2 sequence and expression

    • Connection between CSLM-dependent cell wall properties and adaptation to specific environments

    • Analysis of CSLM2 involvement in stress responses

  • Research Approaches:

    • Cross-species antibody studies to track conservation of protein localization and function

    • Heterologous expression studies to test functional conservation

    • Immunolabeling of diverse plant species to correlate wall composition with ecological niche

    • Genetic manipulation in model and non-model species

  • Potential Significance:

    • Understanding the evolution of complex cell walls in land plants

    • Identifying key innovations in cell wall biosynthesis during plant diversification

    • Connecting cell wall diversity to adaptive strategies

The divergence in key amino acids within the active site of CSLM2 compared to canonical CesA proteins (ES instead of ED, and QxxKW instead of QxxRW) suggests evolutionary adaptation for specialized functions, potentially related to the synthesis of specific cell wall components like type II arabinogalactans .

What interdisciplinary approaches could enhance CSLM2 antibody development and application?

Interdisciplinary approaches offer significant potential for advancing CSLM2 antibody research:

  • Computational-Experimental Integration:

    • Machine learning models for predicting antibody specificity and affinity

    • Molecular dynamics simulations of antibody-antigen interactions

    • Biophysics-informed models for antibody design based on phage display data

    • Structure-based epitope prediction and antibody engineering

  • Bioengineering Approaches:

    • Microfluidic systems for high-throughput antibody screening

    • Novel immobilization strategies for difficult-to-access cell wall epitopes

    • Advanced biomaterials incorporating antibodies for controlled release studies

    • Synthetic biology approaches to engineer novel detection systems

  • Cross-disciplinary Applications:

    • Agricultural biotechnology: Engineering cell walls for enhanced stress resistance

    • Bioenergy research: Modifying cell walls for improved degradability

    • Materials science: Developing plant-inspired biomaterials

    • Medical research: Translating plant glycobiology insights to human systems

  • Collaborative Framework:

    • Partnerships between structural biologists, immunologists, and plant scientists

    • Integration of glycobiology and protein engineering expertise

    • Collaboration between academic and industrial researchers

The successful development of biophysics-informed models for antibody design demonstrates the value of interdisciplinary approaches combining experimental selection techniques with computational modeling . Similar approaches could be applied specifically to CSLM2 antibody development.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.